Capitol Federal Financial, Inc. (CFFN) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US14057J1016
Capitol Federal Financial, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 16.30 m USD |
| EBIT | 83.02 m USD |
| Net income | 68.03 m USD |
| Diluted EPS – continuing operations | 0.52 USD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Capitol Federal Financial, Inc.
Capitol Federal Financial, Inc. operates as the holding company for Capitol Federal Savings Bank that provides various retail banking products and services in the United States. The company offers a range of deposit products, including savings accounts, money market accounts, interest-bearing and non-interest-bearing checking accounts, and certificates of deposit, as well as retirement accounts. It also provides various loan products, such as one- to four-family residential real estate loans, commercial real estate, commercial and industrial, and construction loans, as well as consumer loans, which include home equity loans and lines of credit, home improvement loans, vehicle loans, and loans secured by savings deposits. In addition, the company offers mobile, telephone, and online banking services, as well as bill payment services and mortgage loan; operates a call center; and invests in various securities and mortgage-backed securities. Capitol Federal Financial, Inc. was founded in 1893 and is headquartered in Topeka, Kansas.
More stocks
- MYERS INDUSTRIES INC (MYE)
- Sunwave Communications Co Ltd (002115.SZ)
- Seneca Foods Corp (SENEB)
- Nhn Entertain (181710.KS)
- Willdan Group, Inc. (WLDN)
- JPG (5323.KL)
- Innovative Medical Management Co Ltd (002173.SZ)
- CNB FINANCIAL CORP/PA (CCNE)
- Compagnie des Alpes SA (CDA.PA)
- Janux Therapeutics, Inc. (JANX)
- Aurisco Pharmaceutical Co Ltd (605116.SS)
- Zhongli Science and Technology Group Co Ltd (002309.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.